Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Split-Face, Double-Blind, Placebo-Controlled Study Assessing the Use of a Novel Exfoliative Serum With A Chemical Peel to Improve Photodamage

NCT05908825 is registered in ClinicalTrials.gov with Austin Institute for Clinical Research as lead sponsor.

NCT NCT05908825
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05908825 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Split-Face, Double-Blind, Placebo-Controlled Study Assessing the Use of a Novel Exfoliative Serum With A Chemical Peel to Improve Photodamage
Lead sponsor
Austin Institute for Clinical Research
Phase
Not applicable
Overall status
Completed
Start date
June 22, 2023
Completion date
January 26, 2024
Enrollment
34 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

photodamaged skin